Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Issue

Free This issue is open to the public.

Alert me when new journal issues are available via or via

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Volume 2, Issue 3, Supplement (July 2006)

Search Within This Issue

Alzheimer's Association 10th International Conference on Alzheimer's Disease and Related Disorders

15 July 2006 - 20 July 2006

Viewing 1-60 of 2255 Next 60 Articles>

Page: [1] 2 3 >

Display:

PL-01-01: Early detection of people at risk: Opportunities & challenges
Monique Breteler
page S1
Full Text | Full-Text PDF (128 KB)

PL-01-02: Genetics
Steven Younkin
page S1
Full Text | Full-Text PDF (128 KB)

PL-01-03: Long-term treatment of Alzheimer’s disease
Serge Gauthier
pages S1-S2
Full Text | Full-Text PDF (189 KB)

S1-01-01: Homocysteine: Causal risk factor or prognostic marker?
David Smith
page S2
Full Text | Full-Text PDF (104 KB)

S1-01-02: Glucocorticoid receptor gene variant and risk of dementia and white matter lesions
E. van Rossum
page S2
Full Text | Full-Text PDF (104 KB)

S1-01-03: Diabetes
Richard Mayeux
page S2
Full Text | Full-Text PDF (104 KB)

S1-01-04: Estrogens / endogeneous & exogeneous
Kristine Yaffe
page S3
Full Text | Full-Text PDF (54 KB)

S1-01-05: Testerone levels, genetic polymorphisms and Alzheimer’s disease
Eva Hogervorst
page S3
Full Text | Full-Text PDF (54 KB)

S1-01-06: Integrative view of metabolic syndrome features—from cardiovascular disease to dementia
Miia Kivipelto
page S3
Full Text | Full-Text PDF (54 KB)

S1-02-01: Gamma-secretase: Relationship between gamma-cleavage and epsilon-cleavage
Maho Morishima-Kawashima, Yasuo Ihara
pages S3-S4
Full Text | Full-Text PDF (65 KB)

S1-02-02: Gamma-secretase complex assembly and intramembrane proteolysis by G x G D proteases
Christian Haass, Christoph Kaether, Harald Steiner, Regina Fluhrer
page S4
Full Text | Full-Text PDF (55 KB)

S1-02-03: Pharmacological modulation of AB42 generation (by NSAIDs)
Edward Koo
page S4
Full Text | Full-Text PDF (55 KB)

S1-02-04: Role of AB oligomers in AD
Dennis Selkoe, Matthew Townsend, Ganesh Shankar, Tapan Mehta, Marcia Podlisny, Dominic Walsh
page S4
Full Text | Full-Text PDF (55 KB)

S1-02-05: Degradation of AB
Takaomi Saido
page S4
Full Text | Full-Text PDF (55 KB)

S1-02-06: Clearance of Aβ
Berislav V. Zlokovic
pages S4-S5
Full Text | Full-Text PDF (67 KB)

S1-03-01: vCJD and blood transfusion
Robert Will
page S5
Full Text | Full-Text PDF (56 KB)

S1-03-03: A new BSE prion strain
Fabrizio Tagliavini, Raffaella Capobianco, Cristina Casalone, Silvia Suardi, Claudia Miccolo, Maria Grazia Bruzzone, Daniela Gelmetti, Martin Groschup, Gianluigi Zanusso, Maria Caramelli
page S5
Full Text | Full-Text PDF (56 KB)

S1-03-04: Transmission studies of mouse synthetic prions
Giuseppe Legname, Hoang-Oanh Bach Nguyen, Ilia V. Baskakov, Stephen J. DeArmond, Stanley B. Prusiner
page S5
Full Text | Full-Text PDF (63 KB)

S1-03-05: Cellular prion protein as therapeutic target
Giovanna Malucci
page S6
Full Text | Full-Text PDF (53 KB)

S1-03-06: Treatment of transmissible spongiform encephalopathies with doxycycline
Mario Salmona, Ada DeLuigi, Luisa Diomede, Laura Colombo, Claudia Manzoni, Raffaella Capobianco, Michela Mangieri, Claudia Miccolo, Gianluigi Forloni, Fabrizio Tagliavini
page S6
Full Text | Full-Text PDF (53 KB)

S1-04-01: Vascular cognitive impairment: Toward a common approach to preventable senility
Vladimar Hachinski
page S6
Full Text | Full-Text PDF (53 KB)

S1-04-02: Treatment of dementia associate to PD
Murat Emre
page S6
Full Text | Full-Text PDF (53 KB)

S1-04-03: Synuclein: An update
Isidro Ferrer
pages S6-S7
Full Text | Full-Text PDF (63 KB)

S1-04-04: Dementia with Lewy bodies
Ian McKeith
page S7
Full Text | Full-Text PDF (54 KB)

S1-04-05: Neuropathology of frontotemporal dementia
David G. Munoz
page S7
Full Text | Full-Text PDF (54 KB)

S1-04-06: Alzheimer’s disease with amygdala Lewy bodies: A distinct form of Lewy body disease
Dennis Dickson, Hirotake Uchikado
page S7
Full Text | Full-Text PDF (54 KB)

O1-01-01: Synaptic alterations in inferior temporal lobe in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI)
Stephen W. Scheff, Douglas A. Price, Frederick A. Schmitt, Julie A. Schneider, David A. Bennett, Steven T. DeKosky, Elliot J. Mufson
pages S7-S8
Full Text | Full-Text PDF (63 KB)

O1-01-02: Mitochondrial alterations in relation to synaptic pathology in Alzheimer’s disease
Stavros I. Baloyannis
page S8
Full Text | Full-Text PDF (54 KB)

O1-01-03: Alzheimer disease pathology influences the impact of cerebral amyloid angiopathy on cognitive decline
Magdalena Quass, Johannes Attems, Kurt A. Jellinger, Felix Lintner
page S8
Full Text | Full-Text PDF (54 KB)

O1-01-04: Inflammatory cell infiltrates are commonly associated with brain vasculature and cerebral amyloid angiopathy in Alzheimer’s disease
Manuel Buttini, Ming Chen, Elizabeth Head, Carl Cotman, Dora Games
pages S8-S9
Full Text | Full-Text PDF (64 KB)

O1-01-05: “Arctic” mutation—a unique tau and amyloid feature in progressive dementia
Nenad Bogdanovic, Tomas Arendt, Lars Lannfelt, Hans Basun, Bengt Winblad, Janne Näslund, Wolfgang Härtig
page S9
Full Text | Full-Text PDF (52 KB)

O1-01-06: Doubly phosphorylated PHF-tau epitops as specific markers in Alzheimer’s disease
David Singer, Jörg Lehmann, Katja Hanisch, Wolfgang Härtig, Ralf Hoffmann
page S9
Full Text | Full-Text PDF (52 KB)

O1-01-07: Somatodendritic accumulation of the active form of glygogen synthase kinase-3beta before tau aggregation in neurons in Alzheimer’s disease
Jean-Pierre Brion, Michale Authelet, Yilmaz Zehra, Karelle Leroy
pages S9-S10
Full Text | Full-Text PDF (66 KB)

O1-01-08: Pathological evidence of dense Alzheimer lesions in the visual association cortex of cognitively intact elderly subjects
Ann C. McKee, Rhoda Au, Howard J. Cabral, Neil W. Kowall, Sudha Seshadri, Carolyn A. Kubilus, Jon Drake, Phillip A. Wolf
page S10
Full Text | Full-Text PDF (57 KB)

O1-02-01: A novel presenilin complex component which modulates gamma- but not epsilon-secretase activity
Paul Fraser, Fusheng Chen, Hiroshi Hasegawa, Gerold Schmitt-Ulms, Toshitaka Kawarai, Christopher Bohm, Taiichi Katayama, Yongju Gu, Nobuo Sanjo, Michael Glista, Ekaterina Rogaeva, Yosuke Wakutani, Raphaelle Pardossi Piquard, Xueying Ruan, Anurag Tandon, Frederic Checler, Philippe Marambaud, Kirk Hansen, David Westaway, Peter St George-Hyslop
page S10
Full Text | Full-Text PDF (57 KB)

O1-02-02: Er-retention and complex assembly of the γ-secretase component Pen2 are mediated by its first transmembrane domain and interaction with Rer1
Christoph Kaether, Johanna Scheuermann, Sonja Zilow, Christian Haass
pages S10-S11
Full Text | Full-Text PDF (67 KB)

O1-02-03: Change of cleavage precision by presenilin-dependent gamma-secretase
Masayasu Okochi, Shinji Tagami, Masatoshi Takeda
page S11
Full Text | Full-Text PDF (59 KB)

O1-02-04: Regulation of APP processing by the familial dementia gene BRI2
Luciano D’Adamio, Shuji Matsuda, Yukiko Matsuda, Luca Giliberto
page S11
Full Text | Full-Text PDF (59 KB)

O1-02-05: Dimerization of the APP transmembrane sequence is critical for Aβ42 generation
Lisa M. Munter, Philipp Voigt, Eric Lindner, Michael Schaefer, Dieter Langosch, Gerd Multhaup
page S11
Full Text | Full-Text PDF (59 KB)

O1-02-06: Genetic dissection of the PS1-ΔExon9 mutation and its attenuated response to Aβ42-lowering NSAIDs
Eva Czirr, Stefanie Leuchtenberger, Anna Schneider, Edward H. Koo, Claus U. Pietrzik, Sascha Weggen
pages S11-S12
Full Text | Full-Text PDF (73 KB)

O1-02-07: Different actions of dipeptidic compounds on presenilins define the enzyme specificity of γ-secretase inhibitor
Taisuke Tomita, Yasuko Takahashi, Haruhiko Fuwa, Yu Konno, Yuichi Morohashi, Toshiyuki Kan, Yasuaki Sugimoto, Tohru Fukuyama, Makoto Sasaki, Hideaki Natsugari, Takeshi Iwatsubo
page S12
Full Text | Full-Text PDF (63 KB)

O1-02-08: Genetic analysis of presenilins in gamma-secretase processing and amyloid deposition in vivo
Hui Zheng
page S12
Full Text | Full-Text PDF (63 KB)

O1-03-01: Microglial activation in patients with mild cognitive impairment and Alzheimer’s disease: A study using [11C](R)-PK11195 and PET
Alie Schuitemaker, Bart N. van Berckel, Ronald Boellaard, Marc A. Kropholler, Mark J. Lubberink, Cees Jonker, Adriaan A. Lammertsma, Philip Scheltens
pages S12-S13
Full Text | Full-Text PDF (74 KB)

O1-03-02: In vivo targeting of antibody fragments to the nervous system for Alzheimer’s disease immunotherapy and molecular imaging of amyloid plaques
Joseph F. Poduslo, Silvina S. Holasek, Muthu Ramakrishnan, Marina Ramirez-Alvarado, Emily J. Gilles, Geoffry L. Curran, Thomas M. Wengenack
page S13
Full Text | Full-Text PDF (63 KB)

O1-03-03: From mild cognitive impairment to Alzheimer’s disease: Preliminary results of a 1H-MRS longitudinal study
Antonio Metastasio, Filippo Tommaso Feliziani, Patrizia Rinaldi, Mariani Elena, Pelliccioli Gian Piero, Tarducci Roberto, Gobbi Gianni, Umberto Senin, Patrizia Mecocci
page S13
Full Text | Full-Text PDF (63 KB)

O1-03-04: Relevance of temporo-parietal atrophy in MCI conversion to Alzheimer’s disease: A voxel-based morphometry study
Jasper D. Sluimer, Giorgos B. Karas, Hugo Vrenken, Ronald A. van Schijndel, Wiesje M. van der Flier, Rutger Goekoop, Serge A.R.B. Rombouts, Philip Scheltens, Frederik Barkhof
page S13
Full Text | Full-Text PDF (63 KB)

O1-03-05: Improved classification of MCI and Alzheimer’s disease using diffusion tensor imaging of cingulum white matter
Michael W. Weiner, Yu Zhang, Geon-Ho Jahng, Whitney Bayne, Susumu Mori, Lothos Schad, Susanne Mueller, AnTao Du, Joel Kramer, Kristine Yaffe, Helena L. Chui, William J. Jagust, Bruce L. Miller, Norbert Schuff
pages S13-S14
Full Text | Full-Text PDF (136 KB)

O1-03-06: Consistency of Resting State Networks across healthy subjects measured with FMRI
Jessica S. Damoiseaux, Serge A.R.B. Rombouts, Frederik Barkhof, Philip Scheltens, Cornelis J. Stam, Stephen M. Smith, Christian F. Beckmann
page S14
Full Text | Full-Text PDF (116 KB)

O1-04-01: Visual hallucinations and Lewy body pathology: A community-based autopsy case series
Debby Tsuang, Eric B. Larson, Elaine R. Peskind, James B. Bowen, Wayne McCormick, Linda Teri, Darcy Jennings-Vavrek, Thomas Montine, Mary Lou Thompson, James B. Leverenz
pages S14-S15
Full Text | Full-Text PDF (124 KB)

O1-04-02: Brain cortical thickness in an FTD3 patient and mutation carriers
Peter Johannsen, Simon F. Eskildsen, Jørgen Nielsen, Elizabeth Fisher, Dora Zeidler, Anders Rodell, Leif Østergaard
page S15
Full Text | Full-Text PDF (52 KB)

O1-04-03: Creutzfeldt-Jakob Disease (CJD) surveillance in Japan: Two distinct subtypes of CJD associated with cadaveric dura mater graft and the first Japanese case of variant CJD
Masahito Yamada, Moeko Shinohara-Noguchi, Tsuyoshi Hamaguchi, Yosikazu Nakamura, Tetsuyuki Kitamoto, Takeshi Sato, Hidehiro Mizusawa, vCJD Working Group, CJD Surveillance Committee, Japan
page S15
Full Text | Full-Text PDF (52 KB)

O1-04-04: Insight in frontotemporal dementia. Conceptual analysis and empirical evaluation of the consensus criterion ″loss of insight″ in frontotemporal dementia
Maria P. Lindau, Lena Kilander, Kathinka Evers
page S16
Full Text | Full-Text PDF (55 KB)

O1-04-05: Neuropsychiatric aspects of Parkinsons disease dementia
Chris Fox, Ian Maidment, Mike Samuel, Paul Shotbolt, Tony David
page S16
Full Text | Full-Text PDF (55 KB)

O1-04-06: Variations on a theme: Lewy bodies and mesial temporal sclerosis in Alzheimer’s disease: A review of 278 autopsy cases
Ronald L. Hamilton
page S16
Full Text | Full-Text PDF (55 KB)

O1-04-07: ″Amygdala predominant″ Lewy body disease: A subtype of Alzheimer’s disease with a more aggressive clinical course
James B. Leverenz, Eric B. Larson, Darcy Vavrek, Elaine R. Peskind, James D. Bowen, Wayne C. McCormick, Linda Teri, Walter A. Kukull, Thomas J. Montine, Debby W. Tsuang
pages S16-S17
Full Text | Full-Text PDF (91 KB)

O1-04-08: Left orbitofrontal atrophy correlates with disinhibition and apathy in frontotemporal degeneration
Tiffany W. Chow, Malcolm A. Binns, Morris Freedman, Donald T. Stuss, Joel Ramirez, Nicolaas P.L.G. Verhoeff, Sandra E. Black
page S17
Full Text | Full-Text PDF (82 KB)

O1-05-01: Defining normality: Deviation from longitudinally derived cognitive norms more accurately predicts disease
Susan De Santi, Juan Li, Kimberley Rogers, Schantel Williams, William Barr, Elizabeth Pirraglia, Steven Ferris, Barry Reisberg, Mony de Leon
page S17
Full Text | Full-Text PDF (82 KB)

O1-05-02: Cognitive factors of dementia associated with Parkinson’s disease and Alzheimer’s disease
James E. Galvin, David K. Johnson, John C. Morris
page S18
Full Text | Full-Text PDF (52 KB)

O1-05-03: Imagine: A comparative and randomized intervention study on the detection of Alzheimer’s disease in general medicine
Jean François Dartigues, Virginie Rondeau
page S18
Full Text | Full-Text PDF (52 KB)

O1-05-04: A randomized 2-year study of a non pharmacological cognitive intervention on elderly people: Donostia longitudinal study
Elena Urdaneta, Mari Feli Gonzalez, Nerea Galdona, Cristina Buiza, Igone Etxeberria, Javier Yanguas
page S18
Full Text | Full-Text PDF (52 KB)

Display:

Viewing 1-60 of 2255 Next 60 Articles>

Page: [1] 2 3 >